JFG
ADPT icon

Jefferies Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Jefferies Financial Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-42,500
Closed -$285K – 1580
2023
Q2 		$285K Buy
+42,500
New +$316K ﹤0.01% 1339

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Jefferies Financial Group's ADPT Position: Q3 2023 in Review

Jefferies Financial Group sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 42,500 shares — an estimated $285K sold.

Jefferies Financial Group first reported a position in ADPT in Q2 2023 and held it in 1 quarter. The position peaked at $285K in Q2 2023. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

  • Jefferies Financial Group reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 42,500 Adaptive Biotechnologies shares in Q3 2023, an estimated $285K.
  • Jefferies Financial Group first reported a position in Adaptive Biotechnologies in Q2 2023 and held it in 1 quarter.
  • Jefferies Financial Group's Adaptive Biotechnologies position peaked at $285K in Q2 2023.
  • 190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.